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Background: Contrast induced nephropathy (CIN) is associated with significant morbidity
and mortality after percutaneous coronary intervention (PCI). The aim of this study is to
evaluate the collective probability of CIN in Indian population by developing a scoring
system of several identified risk factors in patients undergoing PCI.
Methods: This is a prospective single center study of 1200 consecutive patients who un-
derwent PCI from 2008 to 2011. Patients were randomized in 3:1 ratio into development
(n ¼ 900) and validation (n ¼ 300) groups. CIN was defined as an increase of 25% and/or
0.5 mg/dl in serum creatinine at 48 hours after PCI when compared to baseline value.
Seven independent predictors of CIN were identified using logistic regression analysis -
amount of contrast, diabetes with microangiopathy, hypotension, peripheral vascular
disease, albuminuria, glomerular filtration rate (GFR) and anemia. A formula was then
developed to identify the probability of CIN using the logistic regression equation.
Results: Themean (±SD) age was 57.3 (±10.2) years. 83.6% were males. The total incidence of
CIN was 9.7% in the development group. The total risk of renal replacement therapy in the
study group is 1.1%. Mortality is 0.5%. The risk scoring model correlated well in the vali-
dation group (incidence of CIN was 8.7%, sensitivity 92.3%, specificity 82.1%, c statistic 0.95).
Conclusion: A simple risk scoring equation can be employed to predict the probability of CIN
following PCI, applying it to each individual. More vigilant preventive measures can be
applied to the high risk candidates.
Copyright © 2014, Cardiological Society of India. All rights reserved.ission, 4-A, J.J Nagar, M
(S.M. Victor).
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Contrast induced nephropathy (CIN) occurs due to acute
kidney injury caused by the contrast media and is a common
cause of hospital-acquired acute renal failure.1 It is associ-
ated with increased morbidity and mortality as well as pro-
longed duration of hospital stay, need for renal replacement
therapy and major cardiac events.2 CIN is defined as a 25%
increase in serum creatinine from the baseline value, or an
absolute increase of at least 0.5 mg/dL (44.2 mmol/L),
48e72 hours after the administration of radiographic contrast
media that is not attributable to other causes.3,4 At least two
significant processes are known to be involved in the patho-
physiology of CIN- vasoconstriction resulting in medullary
hypoxia and direct toxicity caused by the contrast media to
renal tubular cells.5 The mechanisms that have been impli-
cated in these processes are dehydration, decreased prosta-
glandin and nitric oxide induced vasodilatation, impaired
endothelial function, increase in renal adenosine concen-
tration, increase in oxygen free radicals in response to
hyperosmotic load, increased intratubular pressure owing to
contrast induced diuresis, increased urinary viscosity and
obstruction of the tubules.
Percutaneous coronary intervention (PCI) is a life saving
procedure in the management of acute coronary syndrome
and improves the quality of life in patients with stable cor-
onary artery disease. However, PCI poses a risk of CIN due to
the exposure to contrast media during the procedure.
Various risk factors were identified based on studies con-
ducted previously. Advanced age, female gender, anemia,
pre-existing renal impairment, diabetes mellitus, reduced
intravascular volume, congestive cardiac failure, presence of
hypotension, presence of cardiogenic shock, use of intra
aortic balloon pulsations (IABP), type of contrast media, large
volumes of contrast media, co-administration of nephro-
toxic drugs such as angiotensin-converting enzyme in-
hibitors (ACEI), angiotensin II receptor blockers (ARB),
proteinuria (including nephrotic syndrome), multiple
myeloma, hypercholesterolemia, hyperuricaemia, hypercal-
cemia, sepsis, atopic allergy are some of the recognized risk
factors.6e8 Application of risk scoring systems can prognos-
ticate the high risk patients for CIN after the exposure to
contrast.9
Though there are various risk scoring systems available
for prediction of CIN, the risk factor profile and their cu-
mulative effect in Indian patients has never been consid-
ered in large studies, to our knowledge. This has prompted
us to conduct this prospective study with an aim to detect
the incidence of CIN, to identify the predictors and to
determine their collective effect in the development of CIN
in an unselected population of consecutive patients under-
going PCI in our institution. This risk scoring system is
unique to the Indian subcontinent and may also form a
model for other countries across the world with similar
disease patterns.2. Materials and methods
2.1. Aims
To evaluate the collective risk of CIN in Indian population by
developing a scoring system of several identified risk factors,
in patients undergoing PCI.2.2. Objectives
1. To determine the incidence of CIN in the study group
following PCI.
2. To identify the risk factor profile for CIN in Indians and to
compare it with the results of studies conducted
elsewhere.
3. To estimate the cumulative risk rendered by individual risk
factors and to develop a simple risk score model to predict
CIN.
4. To validate this model in a sample patient population.2.2.1. Study population
This is a prospective single center observational study, con-
ducted in Madras Medical Mission, Chennai, which is a ter-
tiary cardiac referral center, from March 2008 to December
2011. 3152 patients underwent PCI during this period. Patients
who were other than Indians, patients in whom the required
data is missing were excluded from the study, apart from the
defined exclusion criterion. Majority of the patients were
excluded (approximately 80%) because PCI was performed
within 14days of coronary angiogram (CAG). The remaining
1200 patients were analyzed for the study. Written informed
consent was obtained from patients and the study is cleared
by the institutional ethics committee.
2.2.2. Study protocol
Patients' age, history including diabetes, hypertension, hy-
pothyroidism, liver disease, multiple myeloma, cerebro
vascular accident (CVA), congestive heart failure (CHF),
chronic kidney disease (CKD), nephrotoxic drugs and pres-
ence of acute coronary syndrome (ACS) were noted. Detailed
clinical examination was done for all patients including
testing for the presence of peripheral vascular disease (PVD),
neuropathy or retinopathy. Diabetic microangiopathy was
considered to be present when either retinopathy (fundus
examination) or neuropathy (monofilament examination)
was present. Patients with diabetic nephropathy were
included in the CKD group. Presence of PVD was confirmed
using Doppler ultrasound if the physical examination
including ankle-brachial index was suggestive of the diag-
nosis. Hemoglobin, total and differential white cell count,
erythrocyte sedimentation rate (ESR), serum bilirubin levels,
plasma glucose levels, albuminuria, electrolytes, lipids and
thyroid profile (if there is a clinical suspicion) were assessed
before the procedure by standardized tests in our laboratory.
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done for all the patients. Serum creatinine, blood urea,
cardiac enzymes were checked at baseline and 48 hours
after the procedure. During the procedure e the number of
vessels diseased, number of vessels stented, the type and
amount of dye used, the presence of periprocedural hypo-
tension and the duration of hypotension were noted
meticulously. All patients underwent PCI using non ionic
contrast media. Post procedure, patients' urine output, need
for renal replacement therapy (RRT) and outcome were
documented. All patients with raised creatinine levels were
given hydration with half normal saline (1 ml/kg/h starting
from 4 hours before and continued till 24 hours after the
exposure to contrast media) and N-acetylcysteine (600 mg
twice daily 1 day before and for 2 days post procedure) as per
the hospital guidelines. All patients received dual anti
platelets and a statin in recommended doses. Data was
collected by persons who were blinded to the study
objectives.
2.2.3. Inclusion criteria
All consecutive Indian patients who underwent PCI in our
hospital fromMarch 2008 to December 2011were enrolled into
the study.
2.2.4. Exclusion criteria
Patients with renal failure on regular dialysis, acute renal
failure before PCI, cardiogenic shock, patients who were
exposed to contrast media within 14 days, patients requiring
intra-aortic balloon pump (IABP) support and patients who
developed PCI related complications were excluded.2.3. Definitions
CIN was defined as an increase of 25% and/or 0.5 mg/dl in
serum creatinine at 48 hours after PCI when compared to
baseline value.10
Anemia was defined as hemoglobin <13 g/dl in men and,
<12 g/dl for women.11
CKD was defined as the estimated GFR <60 ml/mt/1.73 m2
or baseline serum creatinine >1.5 mg/dl.12
Hypotension was defined as systolic blood pressure
<80 mm Hg for at least 1 hour requiring inotropic support
within 24 hours periprocedurally.13
Cardiogenic shock was defined as prolonged hypotension
(systolic blood pressure <85 mm Hg) with evidence of
decreased organ perfusion caused by severe left ventricular
dysfunction, right ventricular infarction, or mechanical com-
plications of infarction and not due to hypovolemia, bra-
dyarrhythmias, or tachyarrhythmias.14
GFR was calculated using the CockcrofteGault formula15:
(ml/mt)ð140 age in yearsÞ weight ðkgÞ  0:85 ðif femaleÞ=72 serum cre2.4. Statistical analysis
Data were collected and managed on the Excel worksheet.
Quantitative variables were expressed as the minimum,
maximum, mean, standard deviation (SD) and qualitative
variables were expressed as frequencies and percentage. Un-
paired student's ‘t’ test was used to compare the mean of
continuous variables. Chi-square test was used to compare
proportions. Univariate and multivariate analysis was per-
formed to identify individual risk factors. ‘p’ value <0.05 was
considered statistically significant. Analyses were conducted
using SAS version 9.2 by Norwich clinical services, Bangalore.
2.5. Risk score system development
1200 consecutive patients undergoing PCI were randomized in
a 3:1 manner to development and validation groups using
simple randommethod. 900 patients were in the development
set and 300 patients were in the validation set. The baseline
clinical, laboratory and procedural characteristics of the pa-
tients in the development set were studied using univariate
analysis to identify the individual risk factors. Significant in-
dividual risk factors were used as independent variables and
CIN as the dependent variable in the final multivariate logistic
regression model without intercept. No variables were trans-
formed during model building. Forward step wise logistic
regression analysis was used to elucidate the final risk factors
with the strongest prediction of CIN using analysis of devi-
ance. Probability value of 5% threshold was used in the for-
ward selection model building process. The obtained logistic
regression equation (A ¼ P bixi, where ‘A’ is estimated CIN
occurrence, ‘b’ ¼ logistic regression coefficient,
‘x’ ¼ independent variable and ‘i’ ¼ 1 to n), the probability of
CIN was estimated with “eA/(1 þ eA)”, where ‘e’ is exponential.
Chi square goodness of fit test was used to assess the final
model accuracy for prediction of CIN and area under curve
(AUC) of receiver operating characteristic (ROC) was used to
evaluate the model discrimination between patients with and
without CIN. The final estimate for CIN probability was eval-
uated using sensitivity and specificity analysis at various cut
off levels (2.5%e60%). The final risk score system was then
substantiated in the validation data set and its predictive ac-
curacy was assessed using the ‘c’-statistic.3. Results
The baseline clinical, laboratory and procedural character-
istics of the patients are in Table 1. The mean (±SD) age was
57.3 (±10.2) years. 83.6% were males. Diabetes and hyper-
tension were prevalent at 53% & 52.2%. The total incidence
of CIN in the development set was 9.7% (n ¼ 87). 11.5%atinine ðmg=dlÞ
Table 3 e Independent Predictor variables of CIN using
Forward Stepwise Logistic Regression without intercept.
Variable b ‘p’ OR 95% CI
Hypotension 1.6382 0.0004 5.15 2.06e12.83
Albuminuria 1.3392 0.0002 3.82 1.87e7.77
DM with microangiopathy 1.5274 0.0012 4.60 1.83e11.60
Anemia 0.2889 <0.0001 0.75 0.67e0.83
Peripheral vascular disease 1.8777 0.0050 6.54 1.76e24.24
GFR 0.0401 <0.0001 0.96 0.95e0.97
Contrast volume 0.0280 <0.0001 1.03 1.02e1.03
b ¼ logistic correlation coefficient.
Table 1 e The baseline clinical, laboratory and procedural
characteristics of development data set.
Variable Mean/% SD
Age (in years) 57.3 10.2
Males 83.6% (n ¼ 752)
Females 16.4% (n ¼ 148)
Multivessel stenting 24.1% (n ¼ 217)
Hypotension 4.9% (n ¼ 44)
Mild LV dysfunction 24.2% (n ¼ 218)
Moderate LV dysfunction 20.3% (n ¼ 183)
Severe LV dysfunction 5.3% (n ¼ 48)
Good LV function 50.1% (n ¼ 451)
Hypertension 52.2% (n ¼ 470)
Congestive heart failure 2.2% (n ¼ 20)
Previous CABG 4.7% (n ¼ 42)
Previous CAD 19.7% (n ¼ 177)
ACS 10.2% (n ¼ 92)
CVA 2.2% (n ¼ 20)
Chronic kidney disease 5.8% (n ¼ 52)
Peripheral vascular disease 3.1% (n ¼ 28)
Hypothyroidism 5.6% (n ¼ 50)
Chronic liver disease 1.6% (n ¼ 14)
Smokers 28.4% (n ¼ 256)
Diabetes 53% (n ¼ 477)
DM with microangiopathy 5.9% (n ¼ 53)
Albuminuria 12.1% (n ¼ 109)
Heart Rate 76.9 12.9
Systolic BP 128 19.3
Diastolic BP 77.8 12
Hemoglobin (g/dl) 12.9 1.7
White cell count (/ml) 9111.1 2986.9
Serum creatinine (mg/dl) 0.9 0.3
Urea (mg/dl) 25.3 11.6
Total Bilirubin (mg/dl) 0.5 0.3
Naþ (mEQ/L) 136.3 4.3
Kþ (mEQ/L) 4.0 0.4
Total Cholesterol (mg/dl) 148.6 41.5
Triglycerides (mg/dl) 148.1 91.4
LDL e Cholesterol (mg/dl) 88.9 35.4
HDL e Cholesterol (mg/dl) 33 8.7
GFR (ml/mt/1.73 m2) 85.8 21.4
Duration of hospital stay (days) 4.1 1.4
Contrast volume (ml) 114.9 37.9
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ment therapy and mortality was 5.7% (n ¼ 5), there was no
mortality in the group without CIN (p < 0.05). The average
hospital stay in the non CIN group was 3.9 (±1.35) daysTable 2 e Univariate Analysis for predictors of CIN.
Variable OR 95% CI ‘p’
Age 2.96 1.72e5.09 <0.0001
Albuminuria 8.10 4.97e13.21 <0.0001
Anemia 1.58 1.01e2.46 0.04
CKD 14.18 7.75e25.95 <0.0001
Diabetes 2.88 1.74e4.75 <0.0001
Presence of ACS 2.83 1.61e4.97 0.0002
GFR 7.46 4.46e12.47 <0.0001
Severe LV dysfunction 3.30 1.99e5.46 <0.0001
Peripheral vascular disease 10.94 5.02e23.84 <0.0001
Contrast volume 51.65 12.62e211.32 <0.0001
Hypotension 13.55 7.12e25.81 <0.0001
Hypothyroidism 7.05 3.78e13.13 <0.0001
DM with microangiopathy 21.94 11.87e40.57 <0.0001where as it was 5.03 (±1.97) days in the CIN group
(p < 0.001).
Univariate analysis has shown a total of 13 variables to be
associated with CIN. These are e age >70 years, presence of
hypotension during the procedure, CKD, PVD, hypothyroid-
ism, presence of ACS, severe left ventricular dysfunction,
diabetes as well as diabetes associated with microangiopathy,
anemia, albuminuria, low GFR (<80 ml/mt/1.73 m2) and
contrast volume (Table 2). The factors that were significant in
univariate analysis were then studied in multivariate analysis
using forward logistic regression to discover independent
predictors. Seven final variables (Table 3) were entered into
the logistic regression equation and the final risk score system
was developed (Table 4). This risk score system is expected to
have a sensitivity of 83.9% and specificity of 89.5% at cut off
probability of predicted CIN at 10% and above.3.1. Validation of risk scoring system
The scoring system was then assessed in the validation data
set to ensure accuracy. The incidence of CIN was 8.7% (n ¼ 26)
in the validation set. Rate of renal replacement therapy was
15.4% (n ¼ 4) and mortality was 7.7% (n ¼ 2) in the CIN group.
The risk score system had a higher sensitivity than expected
at 92.3%, specificity was 82.1% and demonstrated excellent
discriminative power (c e statistic ¼ 0.95) in the validation
group. The model correlation between development and
validation data sets has been shown in Fig. 1 and the relation
between the increasing risk score and incidence of CIN is
shown in Fig. 2. Figs. 3e5 depict the influence of decreasingTable 4 e The final Risk Scoring System for prediction of
CIN.
Clinical predictors To be entered into the equation
GFR Value (ml/mt/1.73m2)
Amount of Contrast Value (ml)







Peripheral vascular disease Yes
No
Fig. 1 e The observed high values of under curve (AUC) of ROC shown on the development data set and validation data set
indicate that predicted CIN model correlated well on its calibration and discriminative characteristics. ‘A’ e development
data set. ‘B’ e validation data set.
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outcome of CIN.4. Discussion
Coronary artery disease has reached epidemic proportions in
India. Percutaneous coronary intervention is a life savingFig. 2 e The relation between the increasing risk score and incide
set. The correlation coefficient of incidence of CIN with predicted
validation set, ‘r’ ¼ 0.78 (p < 0.0001).procedure formanypatients andoccupiesa significantplace in
the practice of interventional cardiology. As the number of
coronary interventions increase, so do the consequent com-
plications such asCIN. CIN contributes to significantmorbidity
and mortality after PCI. Hence, identification of high risk pa-
tients for CIN by risk stratification is indispensable.
Prior studies have reported varying levels of incidence of
CIN; it is 9.7% in our study, 13.1% in the study conducted bynce of CIN. ‘A’ e development data set. ‘B’ e validation data
score in development set, ‘r’¼ 0.69 (p < 0.0001), and in the
Fig. 3 e The increasing rates of CIN with decreasing GFR
values are depicted below.
Fig. 5 e Occurrence of CIN with and without presence of
hypotension.
i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) 5 1 7e5 2 4522Mehran et al13 and 5.5% in the study conducted by Amal Abdel
Ghani et al.16 In an analysis by McCullough et al the incidence
of CIN in patients undergoing PCI is 14.5% (in the derivation
set of 1826 patients).17 Overall, 0.8% required dialysis and the
rate of dialysis was 35.7% in the CIN group. In-hospital mor-
tality rates were 1.1% for patients without CIN and 7.1% for
patients with CIN, all values were statistically significant. In
our study, the rate of dialysis was 11.4% and mortality was
5.7% in the CIN group, there was no account of dialysis or
mortality in the non CIN group. This may be due to the
stringent exclusion criteria we have followed in our study to
eliminate patients who are at high risk for events other than
CIN.
Various factors have been identified as riskmarkers for CIN
in different studies. Diabetes mellitus is proven to be a strong
predictor for CIN.13,17,18 However, in our study diabetes alone
did not influence the outcome of CIN, but if it is associated
with any microvascular consequences like retinopathy or
neuropathy, then it is a strong predictor. This may be because
of the higher ratio of diabetics (53%) in this study and it also
indicates that diabetes not per se but when associated withFig. 4 e Line diagram showing the exponential rise of CIN
with increasing contrast volume.microangiopathy is a bad prognostic factor for CIN. Unlike
other studies, we found that older age13,18 or female
gender16,19 are not independent predictors for CIN, this may
be due to the under representation of these subgroups in this
study (age >70 years13% and female gender e 16.4%). This is
not uncommon in the Indian context where elderly or females
receive fewer coronary interventions20 and those who do
receive usually belong to the higher economic strata and
hence may represent lower risk peer group. Other established
risk factors like peripheral vascular disease,21,22 albumin-
uria,23,24 anemia,13,25 hypotension,13,18 renal impairment17,22
and high contrast volume13,26 form the rest of the compo-
nents of this risk scoring system.
Similar risk prediction models have been published previ-
ously.13,16,21 Mehran et al developed and validated a scoring
system in 8357 patients with eight variables consisting of
hypotension (5 points), IABP (5 points), congestive heart fail-
ure (5points), chronic kidney disease (4 points), diabetes (3
points), age 75 years (4 points), anemia (3 points), and vol-
ume of contrast (1 point for each 100 cc). Based on the attained
score, patients were further divided into low, moderate, high,
very high risk groups, and the incidence of CIN, risk of RRT and
mortality were calculated for each group. Our risk scoring
system differs from this in few aspects. We have excluded
IABP patients in our study as IABP use itself may precipitate
renal dysfunction either by releasing atheroembolic milieu to
renal circulation or by impeding the renal blood flow if placed
low in the aorta and thus making it difficult to differentiate it
from CIN. Albuminuria, which is a significant factor in our
study, was not included in the analysis by Mehran et al. Our
risk scoring system allows risk calculation pertaining to each
individual rather than to a cluster. It also allows the actual
values of the variables to be entered in to the formula rather
than group them further, hence it is convenient to use, even
when there is lack of standardized definitions pertaining to
Indian population for diagnosis, as in the case of anemia.
However, no formula to calculate individual risk of RRT or
mortality was developed in this study. Thus, the scoring sys-
tem proposed in this study is formed by easily available clin-
ical, laboratory and procedural variables and allows
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 5 1 7e5 2 4 523identification of high risk groups for developing CIN, allowing
prophylactic measures to be employed early.5. Study limitations
This is a study involving a single center in south India, hence
multicentric validation across the country is required to
authenticate this scoring system. This study does not involve
the identificationof long term implicationsofdevelopingCIN.A
further follow up of patients would have delineated the same.6. Conclusions
CIN is a frequent complication following PCI, and is associated
with complicated hospital stay and high mortality rate. The
risk factor profile in Indian population as determined by this
study is unique to the subcontinent and may also be appli-
cable to other countries across theworld. A simple risk scoring
system can be developed using easily available clinical and
procedural information to predict the probability of CIN
following PCI. High risk groups can be identified using this risk
scoring system and more vigilant preventive measures can
then be applied for the prophylaxis of CIN.
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